Search / 149 results found

from
to
  • Updated

TEL AVIV, Israel and BETHESDA, Md., Oct. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that EDISON Group issued a Healthcare QuickView publication on the company prepared by Analyst Will Manuel.

  • Updated

TEL AVIV, Israel and BETHESDA, Md., Oct. 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Company Director, Dr. Inbar Maymon-Pomeranchik, will participate at the MjBizCon in Las Vegas on 20-22 of October, 2021.

TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Company CEO, Eyal Barad, will present at the upcoming Edison Open Forum: Cannabinoids 2021, taking place today, Wednesday, October 19th. Mr. Barad's talk will focus on the pharmaceutical development of synthetic cannabinoid-based drug candidates for colorectal cancer and other cancers designated for FDA regulatory review.

  • Updated

RYE BROOK, N.Y., Oct. 18, 2021 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time they shop, are teaming up for the 20th consecutive year to raise critical funds for lifesaving research and treatments for children with blood cancer. In honor of this milestone, Burlington has made a commitment to raise funds with the help of their customers in support of the LLS Children's Initiative, dedicated to supporting children and their families impacted by the disease. Funds raised in Burlington store locations nationwide will support the research pillar of the LLS Children's Initiative, enabling the organization to add more pediatric research grants to break down the barriers that stand in the way of pediatric cancer care innovation, as well as further the mission of LLS.